https://compound11agonist.com/....cyclic-tailor-made-a
Mild adverse events were broadly similar in frequency and type between the dupilumab and placebo groups. No serious adverse events occurred, and none of the adverse events prompted withdrawal from the study medication. Clinical trials showed Dupilumab to be an effective treatment with good patient acceptance. The effectiveness of dupilumab in CHE requires further exploration through larger studies that incorporate longer observation periods. Still further, larger-scale research projects
Giống
Bình luận
Đăng lại
